Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Assisted reproductive technologies Age: Adult |
Dose: Subcutaneous Injection – 0.25 mg Frequency: once daily Duration: until ovulation induction Note: As acetate; administered either in the morning beginning on day 5 or 6 of ovarian stimulation or in the evening beginning on day 5. |
|
Indication: Infertility Treatment Condition: Inhibition of premature LH surges in women undergoing controlled ovarian stimulation |
Dose: Subcutaneous Injection – 0.25 mg Frequency: once daily Duration: until day of human chorionic gonadotropin administration Note: Initiate cetrorelix 0.25 mg subcutaneously once daily during early- to mid-follicular phase. Cetrotide 0.25 mg administered on either stimulation day 5 (morning or evening) or day 6 (morning). |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Child |
Dose: Safety and efficacy not established Note: Safety and efficacy not established |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Mild-to-moderate renal impairment |
Dose: Dosage Form – Not specified Note: Dose adjustment not described by manufacturer |
|
Condition: Severe renal impairment |
Dose: Dosage Form – Not specified Note: Contraindicated |
Administration
- For subcutaneous injection only
- Follow exact timing as prescribed
Side Effect
- Ovarian hyperstimulation syndrome (4%)
- Nausea (1%)
- Hepatic enzyme elevation (1-2%)
- Erythema at injection site
- Itching
- Pruritus
- Swelling
- Redness
- Hypotension
- Rash
- Cough
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
No specific interactions listed, but possibility of interactions with commonly used medicinal products cannot be entirely excluded
|
-
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Moderate to Severe Renal Impairment
|
Risk of drug accumulation
|
|
Moderate to Severe Hepatic Impairment
|
Risk of drug toxicity
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store cetrorelix acetate at room temperature, between 15 to 30° C
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.